K Number
K133336

Validate with FDA (Live)

Date Cleared
2014-07-24

(268 days)

Product Code
Regulation Number
884.5300
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

pjur® Silicone Gel, pjur® Basic Personal Glide, pjur® Light, pjur® Med Premium Glide are personal lubricants, for genital area application, intended to moisturize and lubricate, enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. These products are compatible with natural latex, polyurethane, and polyisoprene condoms.

Device Description

The pjur® family of silicone based lubricants are non-sterile, silicone-based personal lubricants. These over-the-counter products are formulated to be clear, non-irritating, non-greasy, and odorless. The pjur® family of silicone based lubricants contains neither a contraceptive nor a spermicide.

AI/ML Overview

The provided text describes a 510(k) premarket notification for a family of silicone-based personal lubricants. It does not describe an AI device or a study proving its performance against acceptance criteria in the context of AI/medical imaging.

Therefore, I cannot extract the requested information regarding acceptance criteria, study details, sample sizes, expert qualifications, or ground truth establishment because this information is not present in the provided document. The document pertains to the regulatory clearance of a physical consumer product (personal lubricants).

{0}------------------------------------------------

JUL 2 4 2014

K133336 pg 1 of 2

Traditional 510(k) Premarket Notification

pjur group of silicone based lubricants : pjur� Silicone Gel, pjur� Basic Personal Glide, pjur� Light, pjur® Med Premium Glide

Image /page/0/Picture/4 description: The image shows the logo for "pjur group". The logo is black and white. The word "pjur" is in a larger font than the word "group", and there is a circle above the "j" in "pjur". There is a registered trademark symbol to the right of the circle.

510(k) Sum

(as required by 21 CFR 807.92)

Submitterpjur group Luxembourg SA
87 esplanade de la Moselle
L-6637 Wasserbillig, Luxembourg
Telephone: +352 74-8989
Fax: +352 74-8990
Contact PersonPatrick Giebel
Quality Manager
pgiebel@pjurgroup.com
Date PreparedOctober 17th, 2013
Trade Namepjur® family of silicone based lubricants- pjur® Silicone Gel (pjur006)- pjur® Basic Personal Glide (pjur008)- pjur® Light (pjur009)- pjur® Med Premium Glide (pjur021)Predicate DevicesErozone Glide, K040428KY® Intrigue Premium Personal Lubricant, K062796Wet Platinum Premium Lubricant®, K130012TechnologicalCharacteristicsThe pjur® family of silicone based lubricants contain a blend ofsilicone fluid ingredients similar to ingredients found in the predicatedevices.
Common NamePersonal LubricantDescriptionThe pjur® family of silicone based lubricants are non-sterile, silicone-based personal lubricants. These over-the-counter products areformulated to be clear, non-irritating, non-greasy, and odorless. Thepjur® family of silicone based lubricants contains neither acontraceptive nor a spermicide.Performance DataBiocompatibility testing was performed in accordance with ISO 10993-1, "Biological evaluation of medical devices – Part 1: Evaluation andtesting" including:Cytotoxicity Acute irritation Vaginal Irritation and Systemic Toxicity Sensitization via analogue conclusion of testing af pjur002 The results of the testing show that the pjur® family of silicone basedlubricants are not cytotoxic, non-sensitizing, non-irritating, and did notshow any sign of systemic toxicity or vaginal irritation.Testing per ISO 10993-10: 2010 using the Guinea Pig MaximizationStudy demonstrated that the subject devices produced no signs ofallergenic potency. The sensitization rate was 0%. All test resultswere satisfactory and suport that the subject devices poses no unduebiocompatibility risk.Condom compatibility testing was performed using the methodsoutlined in ASTM D7661-10 "Standard Test Method for DeterminingCompatibility of Personal Lubricants with Natural Rubber LatexCondoms." Testing results demonstrate that the pjur® family ofsilicone based lubricants are compatible with natural latex naturallatex, polyurethane, and polyisoprene condoms.
Classification NameCondom(21 CFR §884.5300, Product Code NUC)Intended Usepjur® Silicone Gel, pjur® Basic Personal Glide, pjur® Light, pjur®Med Premium Glide are personal lubricants, for genital areaapplication, intended to moisturize and lubricate, enhance the easeand comfort of intimate sexual activity and supplement the body'snatural lubrication. These products are compatible with natural latex,ConclusionThe pjur silicone based lubricant has the same intended use as thatof Erozone Glide, Wet Platinum Premium Lubricant® and KY®Intrigue. The ingredients in the pjur formulation are the same as inthe Erozone Glide. The labeling claims of the pjur silicone basedpersonal lubricant are the similar as those of the predicates.The labeling of the pjur formulation contains the same warnings andprecautions as those in the labeling of the predicates.Any differences that exist between the pjur silicone based personallubricant formulation and the predicates have no significant effect onthe safety or effectiveness.The pjur silicone based personal lubricant is substantially equivalentto other personal lubricant products cleared in the US in terms ofbiocompatibility, technology, intended use and suitabilitycharacteristics.
ClassClass II

polyurethane, and polyisoprene condoms.

{1}------------------------------------------------

K133336

.

page 2 of 2

Traditional 510(k) Premarket Notification
pjur group of silicone based lubricants : pjur® Silicone Gel, pjur® Basic Personal Glide, pjur® Light, pjur® Med Premium Glide

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the words "Public Health Service" in a bold, sans-serif font. The text is arranged on a single line. The words are black against a white background.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring MD 20993-0002

July 24, 2014

pjur® goup Luxembourg S.A. % Candance F. Cederman Consultant Candace F. Cederman 722 Arjean Drive Wilmington, NC 28411

K133336 Re:

Trade Name: pjur® Silicone Gel, pjur® Basic Personal Glide, pjur® Light, pjur® Med Premium Glide Regulation Number: 21 CFR§ 884.5300 Regulation Name: Condom Regulatory Class: II Product Code: NUC Dated: June 13, 2014 Received: June 16, 2014

Dear Candance F. Cederman,

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing

{3}------------------------------------------------

Page 2 - Candance F. Cederman

(21CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301)796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Benjamin Masher -S

Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use

510(k) Number (if known): _K133336

Device Name: pjur group family of silicone based lubricants

  • piur® Silicone Gel -
  • pjur® Basic Personal Glide ー
  • pjur® Light -
  • pjur® Med Premium Glide, -

Indications for Use:

pjur® Silicone Gel, pjur® Basic Personal Glide, pjur� Light, pjur� Med Premium Glide are personal lubricants, for genital area application, intended to moisturize and lubricate, enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. These products are compatible with natural latex, polyurethane, and polyisoprene condoms.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use _ x (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Beniamin 2014.07.24 04'00'

Page 1 of 1

§ 884.5300 Condom.

(a)
Identification. A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.(b)
Classification. (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.